Arrivent Proposes $75 Million Public Offering of Common Stock and Pre-Funded Warrants
July 1 (Reuters) - Arrivent Biopharma Inc AVBP.O:
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.